Advances in the management of HER2-positive early breast cancer

Erstveröffentlichung

2017

Authors

Baselga, Jose

Coleman, Robert E.

Cortes, Javier

Janni, Wolfgang

Wissenschaftlicher Artikel

Published in

Critical Reviews in Oncology/Hematology ; 119 (2017). - S. 113-122. - ISSN 1040-8428. - eISSN 1879-0461

Link to publication

https://dx.doi.org/10.1016/j.critrevonc.2017.10.001

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[Free subject headings]: Breast cancer | HER2 | Trastuzumab | T-DM1 | Neratinib | Pertuzumab | Lapatinib | epidermal-growth-factor | pertuzumab plus trastuzumab | randomized phase-3 trial | open-label | adjuvant trastuzumab | double-blind | receptor heterodimerization | chemotherapy plus | tyrosine kinase | follow-up
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record